Showing 20 of 223 recruiting trials for “acute-promyelocytic-leukemia”
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia
👨⚕️ Ryan D. Cassaday, MD, Fred Hutch/University of Washington Cancer Consortium📍 1 site📅 Started Apr 2026View details ↗
A Single-arm, Prospective Study of a Cladribine-Bridged LABU Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory MDS/AML in Elderly Patients
👨⚕️ Depei Wu, The First Affiliated Hospital of Soochow University📍 1 site📅 Started Apr 2026View details ↗
Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia
👨⚕️ Justin E Tanner, PhD, St. Jude Children's Research Hospital📍 1 site📅 Started Mar 2026View details ↗
Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
Safety and Proof-of-Concept Study of RPT1G in Adults With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes
Phase Ib Study of CD33 FPBMC in Patients With MRD+ AML or MDS
RecruitingNCT07422337 ↗
A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who Have Received Blinatumomab
👨⚕️ Lauren Appell, MD, Arkansas Children's Research Institute📍 2 sites📅 Started Jan 2026View details ↗
Feasibility Trial of Extracorporeal Iron Purification in Patients With Myelodysplastic Syndrome or Myelofibrosis
Clinical Trial of CMD63 Chimeric Antigen Receptor T-cell (CAR T-cell) in Children With Acute Lymphoblastic Leukemia (ALL)
👨⚕️ Kanhatai Chiengthong, MD, King Chulalongkorn Memorial Hospital📍 3 sites📅 Started Jan 2026View details ↗
Telematic Cognitive Training and Mindfulness in Pediatric Patients After CAR-T Cell Therapy, Single Hematopoietic Allogeneic Transplant or Chemotherapy
Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid Leukemia
A Study of Subcutaneous Blinatumomab in Children With R/R and and MRD+ B-Cell Precursor Acute Lymphoblastic Leukemia
Phase I Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia
👨⚕️ Kevin Curran, MD, Memorial Sloan Kettering Cancer Center📍 3 sites📅 Started Oct 2025View details ↗
Children's Laughter and Fun Yoga as Adjunctive Pain Relief Following Chemotherapy.
👨⚕️ Bahaa W Bou Dargham, MD, Beirut Arab University and Hammoud Hospital University Medical Center📍 1 site📅 Started Oct 2025View details ↗
A Study of CTD402 in T-ALL/LBL Patients
Efficacy of Targeted Drugs Combined With Chemotherapy in the Treatment of T-ALL
👨⚕️ Qifa Liu, Nanfang Hospital, Southern Medical University📍 1 site📅 Started Oct 2025View details ↗
Page 1 of 12Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →